Search for: "Gilead Tenofovir Cases"
Results 21 - 37
of 37
Sorted by Relevance
|
Sort by Date
7 Jan 2018, 12:47 pm
If applied to the combination of tenofovir disoproxil and emtricitabine, this would, according to Mepha’s point of view, lead to the nullity of Gilead’s SPC. [read post]
3 Aug 2018, 8:22 am
Awaiting Warner-Lambert v ActavisOver at the IP Alchemist blog, former Kat Darren Smyth takes a look at the recent decision from the CJEU in the case of Teva v Gilead C-121/17: Teva v Gilead – C-121/17 provides some clarity on combination products. [read post]
4 Feb 2008, 1:07 pm
WARF Stem Cell patents and Gilead Tenofovir (AIDS drug) patents have had all claims non-finally rejected, but are still pending. [read post]
5 Oct 2020, 2:00 am
Over to Raphaëlle, Julie, Luca and Camille:"After the mid-year round up of Dutch and German patent litigation posted by our Kat's friends at Brinkhof and Arnold Ruess, here comes the French one.In this post, we will report on 4 noticeable patent cases of the French Courts in the first half of 2020:The first two are landmark cases dealing with conflicts of jurisdiction in the context of multi-jurisdictional litigation and clearly show that the French Courts will… [read post]
1 Aug 2008, 4:53 pm
Gilead Science managed to win an appeal against an refusal to grant an SPC for a tenofovir patent, thanks to Mr Justice Kitchin. [read post]
9 Dec 2009, 3:59 pm
Teva Pharmaceuticals (PATracer) Viread (Tenofovir) – India: Gilead files appeal in IPAB challenging IPO’s rejection of Viread patents (GenericsWeb) Yaz (Drospirenone, Ethinyl estradiol) – Canada: Court dismisses judicial review of Minister’s decision refusing to list formulation patent on the Patent Register: Bayer v Canada (Health) (Pharmacapsules @ Gowlings) [read post]
22 Nov 2017, 3:14 am
No prizes for guessing which party was attacking which mark.IP Federation declares no role for IP disputes in proposed Hague Convention, while INTA takes a different approachAnnsley talks us through a new draft legislative instrument - the draft Hague Convention on the Recognition and Enforcement of Foreign Judgments.Book review: Grounds of the Immaterial - A Conflict-based Approach to Intellectual Property RightsMathilde reviews Niels van Dijk’s book, Grounds of the Immaterial, A… [read post]
3 Feb 2010, 2:00 am
(Docket Report) Sustiva (Efavirenz) – US: Mylan and Matrix fail in bid to dismiss Sustiva case brought by Bristol Myer Squibb (Patent Docs) Temodar (Temozolomide) – US: District Court Delaware: Temador patent unenforceable due to prosecution laches and inequitable conduct: Cancer Research Tech v Barr Labs (Docket Report) (Patent Baristas) (IP Factor) Viread (Tenofovir) – US: Gilead Sciences announces notification of Teva’s ANDA filing for Viread… [read post]
15 Feb 2011, 5:26 pm
(FDA Law Blog) Diovan (Vasartan) – France: Novartis v Actavis – preliminary injunction for Valsartan confirmed (The SPC Blog) Diovan HTC (Valsartan) – Belgium: Antwerp Court of Appeal stops infringement of Valsartan/HCTZ SPC based on patent claiming Valsartan alone: Novartis v Teva (The SPC Blog) Lescol (Fluvastatin) – US: Novartis files patent infringement complaint against Mylan following Para IV challenge (Patent Docs) (GenericsWeb) Mucinex (Guaifenesin) – US: Watson… [read post]
15 Dec 2010, 2:17 am
Becton, Dickinson & Co (Intellectual Property Law Blog) US: Regents of the University of California pursue new patent re-examination in District Court (Patents Post Grant Blog) US: Microsoft v i4i, the burden of proof and the pharma sector (PatLit) US: IRS issues notice to implement annual fee on brand drugs (FDA Law Blog) US: Bright ‘orphan’ ideas blossom (FDA Law Blog) US: Amicus briefs in AMP v USPTO (Patent Docs) (Patent Docs) (Patent Docs) US: University of California files for… [read post]
21 Nov 2008, 11:36 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Plavix (Clopidogrel) – Canada: Supreme Court upholds selection patents: Apotex v Sanofi-Synthelabo Canada et al (Pharmacapsules @ Gowlings) (Hal… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its… [read post]
23 Aug 2008, 1:23 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
1 Feb 2008, 12:00 am
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]Highlights this week included:Google taking the profit out of domain tasting: (The Trademark Blog), (Canadian Trademark Blog), (Class 46), (Ars Technica),ECJ rules that EU law does not force disclosure of internet users’ details in file-sharing cases in Productores de Música de España (Promusicae) v Telefónica de… [read post]
5 Jul 2008, 11:05 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
13 Jun 2008, 3:40 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA is objecting… [read post]
